Peregrine Pharmaceuticals shares owned by Punch & Associates Investment Management
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Punch & Associates Investment Management
from 13F filings
Historical chart of Punch & Associates Investment Management investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Punch & Associates Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Peregrine Pharmaceuticals by Punch & Associates Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $13M | 1.9M | 6.70 |
2023-12-31 | $8.7M | 1.3M | 6.50 |
2023-09-30 | $11M | 1.2M | 9.44 |
2023-06-30 | $14M | 1.0M | 13.97 |
2023-03-31 | $15M | 819k | 18.76 |
2022-12-31 | $11M | 810k | 13.77 |
2022-09-30 | $16M | 826k | 19.12 |
2022-06-30 | $9.6M | 632k | 15.26 |
2022-03-31 | $13M | 637k | 20.37 |
2021-12-31 | $18M | 618k | 29.18 |
2021-09-30 | $16M | 731k | 21.57 |
2021-06-30 | $20M | 765k | 25.65 |
2021-03-31 | $14M | 758k | 18.23 |
2020-12-31 | $8.6M | 749k | 11.54 |
2020-09-30 | $2.9M | 381k | 7.62 |
More positions owned by Punch & Associates Investment Management
View all positions for Punch & Associates Investment Management